IP Verse

Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs - EP2345425B1

PatentPatent Analysis

EP2345425

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP11162751A
Filing Date
Dec 26, 2006
Status
Revoked
Jun 25, 2021
Grant Date
Jul 11, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3481415B1
EP3806891B1
EP2651978B2

Bibliography

The patent EP2345425B1 was granted to Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Jul 11, 2018 following the initial filing on Dec 26, 2006 under the application number EP11162751A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

OCTAPHARMAApr 11, 2019ADMISSIBLE
TAKEDA PHARMACEUTICALSApr 11, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents